ArticleFrontiers in pharmacology2024

Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database.

Xiping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.